Restrictive cardiomyopathy: Difference between revisions

No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 4: Line 4:
**Ventricular EF typically normal, though systolic function may deteriorate in absence of compensatory hypertrophy
**Ventricular EF typically normal, though systolic function may deteriorate in absence of compensatory hypertrophy
*If nodal/conduction tissues affected by infiltrative/fibrotic process, may cause SA or [[AV block]]
*If nodal/conduction tissues affected by infiltrative/fibrotic process, may cause SA or [[AV block]]
*Must distinguish from constrictive [[pericarditis]]
*Must distinguish from [[constrictive pericarditis]]


==Clinical features==
===Causes of Restrictive Cardiomyopathy===
*Idiopathic
*Familial non-infiltrative disease
*Infiltrative disease ([[amyloidosis]], [[sarcoidosis]], Gaucher, Hurler)
*Storage diseases ([[hemochromatosis]], Fabry, glycogen/lysosomal storage diseases)
*[[Diabetes]]
*[[Scleroderma]]
*Endomyocardial fibrosis (hypereosinophilic syndrome, medication toxicity)
*Radiation, chemotherapy (doxorubicin)
*Metastatic disease, [[carcinoid syndrome]]
 
==Clinical Features==
*Exertional [[dyspnea]], orthopnea, PND
*Exertional [[dyspnea]], orthopnea, PND
*Peripheral edema
*Peripheral edema
Line 17: Line 28:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Constrictive pericarditis]]
{{Cardiomyopathy DDX}}
{{Cardiomyopathy DDX}}
===Restrictive cardiomyopathy etiology DDX===
**Idiopathic
**Familial non=infiltrative disease
**Infiltrative disease ([[amyloidosis]], [[sarcoidosis]], Gaucher, Hurler)
**Storage diseases ([[hemochromatosis]], Fabry, glycogen/lysosomal storage diseases)
**[[Diabetes]]
**[[Scleroderma]]
**Endomyocardial fibrosis (hypereosinophilic syndrome, medication toxicity)
**Radiation, chemotherapy (doxorubicin)
**Metastatic disease, [[carcinoid syndrome]]


==Evaluation==
==Evaluation==
*Consider if [[CHF]] but no evidence of cardiomegaly or systolic dysfunction
===Workup===
*[[ECG]]
*[[ECG]]
**Typically nonspecific ST/TW abnormalities
**Typically nonspecific ST/TW abnormalities
Line 41: Line 43:
**Elevated LV filling pressures, impaired longitudinal contraction
**Elevated LV filling pressures, impaired longitudinal contraction
**+/- dilated atria, myocardial hypertrophy
**+/- dilated atria, myocardial hypertrophy
===Diagnosis===
*Consider if [[CHF]] but no evidence of cardiomegaly or systolic dysfunction
*Definitive diagnosis may require MRI, catheterization, biopsy
*Definitive diagnosis may require MRI, catheterization, biopsy


Line 51: Line 56:
***Avoid [[digoxin]] in amyloidosis as sensitivity to dig-induced arrhythmias common
***Avoid [[digoxin]] in amyloidosis as sensitivity to dig-induced arrhythmias common


==Disposition==


==See Also==
==See Also==
*[[Cardiomyopathy (Main)]]
*[[Cardiomyopathy (main)]]
*[[Constrictive pericarditis]]
 
==External Links==


==References==
==References==
<references/>
<references/>
https://www.merckmanuals.com/professional/cardiovascular-disorders/cardiomyopathies/restrictive-cardiomyopathy
*https://www.merckmanuals.com/professional/cardiovascular-disorders/cardiomyopathies/restrictive-cardiomyopathy


[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 18:43, 14 December 2022

Background

  • Muscle is stiff from fibrosis or infiltrating process (e.g. amyloidosis, hemochromatosis)
  • Form of diastolic dysfunction (difficulty filling); ventricular endocardial thickening or myocardial infiltration-->high filling pressures, impaired diastolic filling-->mitral and/or tricuspid regurgitation--> venous pulmonary hypertension
    • Ventricular EF typically normal, though systolic function may deteriorate in absence of compensatory hypertrophy
  • If nodal/conduction tissues affected by infiltrative/fibrotic process, may cause SA or AV block
  • Must distinguish from constrictive pericarditis

Causes of Restrictive Cardiomyopathy

Clinical Features

Differential Diagnosis

Cardiomyopathy

Evaluation

Workup

showing ST-segment and T-wave abnormalities

  • CXR- heart typically normally sized, though can be enlarged in advanced stages of some underlying disease processes
  • Echocardiography
    • Normal LVEF
    • Elevated LV filling pressures, impaired longitudinal contraction
    • +/- dilated atria, myocardial hypertrophy

Diagnosis

  • Consider if CHF but no evidence of cardiomegaly or systolic dysfunction
  • Definitive diagnosis may require MRI, catheterization, biopsy

Management

  • Symptom-directed
    • Diuretics for edema or pulmonary vascular congestion
      • Caution as cardiac output preload dependant
    • Caution with afterload reduction as may cause profound hypotension
    • Treat arrhythmias
      • Avoid digoxin in amyloidosis as sensitivity to dig-induced arrhythmias common

Disposition

See Also

External Links

References